Prashanth Sirigere Manjunath, MD
Interventional Pain Medicine · Kingman, AZNPI 1629227616
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 47.8% of the total. Reporting peaked in 2021 at $3,688 and has fallen 97.2% since, to $104 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in AZ, where the typical reported total is $8,993.
Across 62 payments — averaging $111.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$3K
- Joline Medical Inc$2K
- Nevro Corp.$1K
- AbbVie$322
- Boston Scientific$104
- SPR Therapeutics, Inc$65
- plus $232 from 9 others
What the payments were for
- Speaking & faculty fees$3,25047%
- Travel & lodging$2,47536%
- Food & beverage$1,21818%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 6 | $3,320 |
| Joline Medical Inc | 1 | $1,600 |
| Nevro Corp. | 24 | $1,299 |
| AbbVie(2 entities) | 15 | $322 |
| Boston Scientific | 1 | $104 |
| SPR Therapeutics, Inc | 1 | $65 |
| Biodelivery Sciences International, Inc. | 4 | $56 |
| Stimwave Technologies Incorporated | 1 | $31 |
| Pfizer | 2 | $30 |
| Lilly USA, LLC | 2 | $26 |
| Abbott | 1 | $25 |
| Avanos Medical | 1 | $21 |
| Medtronic | 1 | $15 |
| Si-bone, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$3,250
- Joline Kyphopasty System Allevo$1,600
- Senza Spinal Cord Stimulation System$875
- GENERAL PAIN MANAGEMENT$104
How this compares
$6,943 in reported general payments places this provider in the 45th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 32 | $4,398 |
| Lidocaine | 45 | $3,401 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 176 | $3,172 |
| Diclofenac Sodium | 88 | $1,963 |
| Duloxetine Hcl | 92 | $1,797 |
| Gabapentin | 148 | $1,578 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 70 | $1,543 |
| Pregabalin | 45 | $958 |
| Celecoxib | 29 | $804 |
| Tizanidine Hcl | 84 | $678 |
| Morphine Sulfate | 21 | $623 |
| Baclofen | 47 | $587 |
| Methocarbamol | 46 | $460 |
| Amitriptyline Hcl | 32 | $441 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $425 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Kingman
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ajay YedduGilbert$52K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
- Sachin NarainGilbert$31K
- Jennifer DaisPeoria$30K
- Brandon RothGlendale$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.